Quantum Cyber N.V. (QUCY): Net Income

Annual figures by period end, from SEC filings.

-$16.21M

Year ended 2025-12-31

-$23.83M

Trailing 12 months to 2026-06-30

2024-12-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	-$16.21M	n/m	2026-03-31, From 2025-01-01
2024-12-31	-$21.60M	n/a	2026-03-31, From 2024-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Quantum Cyber N.V. (QUCY)	2025-12-31	-$16.21M	n/m
Lipella Pharmaceuticals Inc. (LIPO)	2024-12-31	-$5.02M	n/m
Silence Therapeutics plc (SLN)	2025-12-31	-$88.61M	n/m
Yarrow Bioscience, Inc. (YARW)	2025-12-31	-$26.48M	n/m
Mereo BioPharma Group plc (MREO)	2025-12-31	-$41.88M	n/m
PMGC Holdings Inc. (ELAB)	2025-12-31	-$7.75M	n/m
Vaccinex, Inc. (VCNX)	2024-12-31	-$18.63M	n/m
BioXcel Therapeutics, Inc. (BTAIQ)	2025-12-31	-$69.90M	n/m
Polomar Health Services, Inc. (PMHS)	2025-12-31	-$10.70M	n/m

Compare QUCY, LIPO, SLN, YARW side by side · Screen every company in Pharmaceutical Preparations ↗